Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wex gets co-developer payment for pain drug
Wex licensed the European rights to its Tetrodotoxin (TTX) products to Esteve in November 2002 for a commitment of C$62,000,000. This agreement was expanded in March 2005 to
Wex licensed the European rights to its Tetrodotoxin (TTX) products to Esteve in November 2002 for a commitment of C$62,000,000. This agreement was expanded in March 2005 to
Cigarette smoking promotes lung cancer and many other cancers, heart disease, poor circulation, and emphysema. These are the same diseases, which GenoMed has found to be due to
This study is one of multiple phase II clinical trials that Allergan has sponsored to explore the use of its Botox (botulinum toxin type A) product to treat
XP13512 is a transported prodrug of gabapentin, a drug that has been sold by Pfizer as Neurontin since 1993 and is currently sold as a generic drug by
Gleevec (imatinib mesylate) is a targeted therapeutic with global sales in excess of $1.6 billion in 2004. It was first approved in 2001 for the treatment of advanced-stage
The purchase was made pursuant to an equity transfer agreement entered into by Wyeth and Takeda in May 2003. Takeda’s remaining 30% equity in WKK will be acquired
The phase III study was designed to evaluate the efficacy and safety of the oral fumarate in the treatment of moderate to severe psoriasis. The trial met the
Lunesta (eszopiclone) is the first and only sleep aid (prescription or over-the-counter), which has been approved by the FDA for long-term treatment of insomnia. It is also the
AD 452 is a novel, small molecule, disease modifying anti-rheumatic drug (DMARD), designed to reduce joint inflammation and destruction, pain, and preserve mobility. The trial investigated the pharmacokinetics,
The FDA told Pfizer that, although Bextra’s cardiovascular risk could not be differentiated from other non-steroidal anti-inflammatory drugs (NSAIDs), the additional, increased risk of rare but serious skin